KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $13.6 billion.

  • Pfizer's Short-term Investments rose 5396.16% to $13.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $13.6 billion, marking a year-over-year increase of 5396.16%. This contributed to the annual value of $19.4 billion for FY2024, which is 9756.02% up from last year.
  • Per Pfizer's latest filing, its Short-term Investments stood at $13.6 billion for Q3 2025, which was up 5396.16% from $11.6 billion recorded in Q2 2025.
  • In the past 5 years, Pfizer's Short-term Investments registered a high of $42.2 billion during Q3 2023, and its lowest value of $6.0 billion during Q2 2024.
  • Over the past 5 years, Pfizer's median Short-term Investments value was $19.3 billion (recorded in 2021), while the average stood at $20.8 billion.
  • As far as peak fluctuations go, Pfizer's Short-term Investments skyrocketed by 17905.53% in 2021, and later crashed by 8565.23% in 2024.
  • Quarter analysis of 5 years shows Pfizer's Short-term Investments stood at $29.1 billion in 2021, then decreased by 23.38% to $22.3 billion in 2022, then plummeted by 55.92% to $9.8 billion in 2023, then skyrocketed by 97.56% to $19.4 billion in 2024, then dropped by 29.81% to $13.6 billion in 2025.
  • Its last three reported values are $13.6 billion in Q3 2025, $11.6 billion for Q2 2025, and $15.9 billion during Q1 2025.